The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-5,6,7,8-tetrahydro-naphthalene-2-carboxylic acid ethyl ester hydrochloride ID: ALA541542
PubChem CID: 45264302
Max Phase: Preclinical
Molecular Formula: C21H25Cl2NO3
Molecular Weight: 373.88
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1ccc2c(c1)CC(NCC(O)c1cccc(Cl)c1)CC2.Cl
Standard InChI: InChI=1S/C21H24ClNO3.ClH/c1-2-26-21(25)16-7-6-14-8-9-19(12-17(14)10-16)23-13-20(24)15-4-3-5-18(22)11-15;/h3-7,10-11,19-20,23-24H,2,8-9,12-13H2,1H3;1H
Standard InChI Key: NNBDAERRXFAUII-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
14.1932 0.7412 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9122 1.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7928 0.7396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9141 2.6966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0945 1.4850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8942 1.4964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1929 0.7441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4942 1.4919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3910 0.7305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2109 0.7445 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4323 1.3269 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.4963 2.6919 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7877 -0.7605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0842 -1.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3858 -0.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5121 1.4924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5506 0.8910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 1 0
2 5 1 0
4 5 2 0
2 6 2 0
2 8 1 0
3 9 2 0
7 10 2 0
4 12 1 0
6 13 1 0
12 13 2 0
11 14 1 0
7 15 1 0
14 15 1 0
6 16 1 0
8 17 1 0
11 17 1 0
10 18 1 0
3 19 1 0
16 20 1 0
17 20 1 0
18 21 1 0
15 22 1 0
7 23 1 0
23 24 2 0
18 25 2 0
24 25 1 0
19 26 1 0
26 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 373.88Molecular Weight (Monoisotopic): 373.1445AlogP: 3.70#Rotatable Bonds: 6Polar Surface Area: 58.56Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.61CX LogP: 4.42CX LogD: 2.25Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -0.67
References 1. Badone D, Guzzi U. (1994) Synthesis of the potent and selective atypical -adrenergic agonist SR 59062A., 4 (16): [10.1016/S0960-894X(01)80535-7 ]